Frazier Life Sciences Acquisition Corp II (FLSC)
| Market Cap | 99.36M |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 9.68M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 28,343 |
| Open | 10.28 |
| Previous Close | 10.30 |
| Day's Range | 10.28 - 10.29 |
| 52-Week Range | 10.18 - 10.63 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About FLSC
Frazier Life Sciences Acquisition Corp II focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2026 and is based in Palo Alto, California.
News
Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering
PALO ALTO, Calif.--(BUSINESS WIRE)--Frazier Life Sciences Acquisition Corp. II (the “Company”), a special purpose acquisition company, announced today the closing of its initial public offering of 7,5...
Biotech SPAC Frazier Life Sciences Acquisition II files for a $75 million IPO
Frazier Life Sciences Acquisition II, the second blank check company formed by Frazier targeting biotech, filed on Thursday with the SEC to raise up to $75 million in an initial public offering.
Frazier Life Sciences Acquisition II IPO Registration Document (S-1)
Frazier Life Sciences Acquisition II to go public with an IPO on the NASDAQ